Drug General Information
Drug ID	D0M2EN
Former ID	DNC013716
Drug Name	N-butylresorcinol
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529942]
Structure		Download 2D MOL 3D MOL
Formula	C10H14O2
Canonical SMILES	CCCCC1=C(C=C(C=C1)O)O
InChI	1S/C10H14O2/c1-2-3-4-8-5-6-9(11)7-10(8)12/h5-7,11-12H,2-4H2,1H3
InChIKey	CSHZYWUPJWVTMQ-UHFFFAOYSA-N
PubChem Compound ID	205912
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[529942]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 529942	Bioorg Med Chem Lett. 2009 Mar 1;19(5):1532-3. Epub 2009 Jan 1.Studies on depigmenting activities of dihydroxyl benzamide derivatives containing adamantane moiety.
Ref 529942	Bioorg Med Chem Lett. 2009 Mar 1;19(5):1532-3. Epub 2009 Jan 1.Studies on depigmenting activities of dihydroxyl benzamide derivatives containing adamantane moiety.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.